Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2)

AR-JP; LPRS2; PDJ; PRKN; Parkin; Autosomal Recessive,Juvenile; E3 ubiquitin-protein ligase parkin

  • Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2) Packages (Simulation)
  • Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2) Packages (Simulation)
  • Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2) DAB staining on IHC-P; Sample: Rat Kidney Tissue; Primary Ab: 20µg/ml Rabbit Anti-Human PARK2 Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2) DAB staining on IHC-P;
    Sample: Rat Cerebrum Tissue;
    Primary Ab: 20µg/ml Rabbit Anti-Human PARK2 Antibody
    Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2) DAB staining on IHC-P;
    Sample: Rat Testis Tissue;
    Primary Ab: 20µg/ml Rabbit Anti-Human PARK2 Antibody
    Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2) FITC staining on IF;
    Sample: Human U2OS cell;
    Primary Ab: 20µg/ml Rabbit Anti-Human PARK2 Antibody
    Second Ab: 2µg/ml FITC-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb18)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SPECIFITY of the Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2)

The antibody is a rabbit polyclonal antibody raised against PARK2. It has been selected for its ability to recognize PARK2 in immunohistochemical staining and western blotting.

USAGE of the Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2)

Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.

STORAGE of the of the Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2)

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY of the Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPL060Hu01 Recombinant Parkinson Disease Protein 2 (PARK2) Positive Control; Immunogen; SDS-PAGE; WB.
PAL060Hu01 Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2) WB; IHC; ICC; IP.
PAL060Hu02 Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2) WB; IHC; ICC; IP.
MAL060Hu21 Monoclonal Antibody to Parkinson Disease Protein 2 (PARK2) WB; IHC; ICC; IP.
SEL060Hu ELISA Kit for Parkinson Disease Protein 2 (PARK2) Enzyme-linked immunosorbent assay for Antigen Detection.
LML060Hu Multiplex Assay Kit for Parkinson Disease Protein 2 (PARK2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK